Generated by All in One SEO v4.9.3, this is an llms.txt file, used by LLMs to index the site.

# Polarean

## Sitemaps

- [XML Sitemap](https://polarean.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Korean distributor agreement with DK Healthcare in South Korea](https://polarean.com/korean-distributor-agreement-with-dk-healthcare-in-south-korea/)
- [FDA expands XENOVIEW® indication to include children from six years of age](https://polarean.com/fda-expands-xenoview-indication-to-include-children-from-six-years-of-age/)
- [American Thoracic Society honors Dr. Bastiaan Driehuys for pioneering work in Xenon MRI](https://polarean.com/american-thoracic-society-honours-dr-bastiaan-driehuys-for-pioneering-work-in-xenon-mri/)
- [Philips and Polarean partner to bring advanced Xenon lung MRI to more children with chronic obstructive lung disease](https://polarean.com/philips-and-polarean-partner-to-bring-advanced-xenon-lung-mri-to-more-children-with-chronic-obstructive-lung-disease/)
- [Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum](https://polarean.com/xenon-mri-featured-prominently-at-ats-2025-across-broad-clinical-spectrum/)
- [Polarean and SimonMed Announce Collaboration to Advance Lung Imaging Innovation](https://polarean.com/polarean-and-simonmed-announce-collaboration-to-advance-lung-imaging-innovation/)
- [FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems](https://polarean.com/fda-clears-xenoview-3t-chest-coil-in-ge-healthcare-mri-systems/)
- [Appointment of Alan Huang, PhD, as Vice President of Sales](https://polarean.com/appointment-of-alan-huang-phd-as-vice-president-of-sales/)
- [Appointment of Chase Hall, M.D., as Chief Medical Advisor](https://polarean.com/appointment-of-chase-hall-md-as-chief-medical-advisor/)
- [Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives](https://polarean.com/polarean-raises-12-6-million-in-oversubscribed-financing-round-to-accelerate-xenoview-commercialization-and-strategic-growth-initiatives/)
- [Polarean’s Xenon MRI to be Featured at Upcoming ATS 2024 Conference](https://polarean.com/polareans-xenon-mri-to-be-featured-at-upcoming-ats-2024-conference/)
- [Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs](https://polarean.com/polarean-partners-with-vida-to-streamline-adoption-of-advanced-mri-of-the-lungs/)
- [CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology](https://polarean.com/cms-grants-reimbursement-code-for-the-polarean-xenoview-mri-technology/)
- [Polarean Receives Clearance for New MRI Chest Coil](https://polarean.com/polarean-receives-clearance-for-new-mri-chest-coil/)
- [Appointment of Dr. Christopher von Jako as new CEO](https://polarean.com/appointment-of-dr-christopher-von-jako-as-new-ceo/)
- [Collaboration with Philips to be featured at ISMRM 2023](https://polarean.com/collaboration-with-philips-to-be-featured-at-ismrm-2023/)
- [First clinical scan using XENOVIEW™ conducted at Cincinnati Children’s Hospital Medical Center](https://polarean.com/first-clinical-scan-using-xenoview-conducted-at-cincinnati-childrens-hospital-medical-center/)
- [Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit](https://polarean.com/polarean-to-be-a-featured-company-at-2023-ats-respiratory-innovation-summit/)
- [FDA Grants New Chemical Entity designation for XENOVIEW™ (xenon Xe 129 hyperpolarized)](https://polarean.com/fda-grants-new-chemical-entity-designation-for-xenoview-xenon-xe-129-hyperpolarized/)
- [Company Update](https://polarean.com/company-update/)
- [Positive Results Announced from Pivotal Phase III Clinical Trials](https://polarean.com/positive-results-announced-from-pivotal-phase-iii-clinical-trials/)
- [FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized)](https://polarean.com/fda-approves-polareans-xenoview-xenon-xe-129-hyperpolarized-for-use-with-mri-for-the-evaluation-of-lung-ventilation/)
- [Update on New Drug Application](https://polarean.com/update-on-new-drug-application/)
- [NDA Resubmission](https://polarean.com/nda-resubmission/)
- [New System Order](https://polarean.com/new-system-order/)
- [Complete Response Letter Received from FDA](https://polarean.com/complete-response-letter-received-from-fda/)
- [Polarean Announces NDA Submission of <sup>129</sup>Xenon Gas MRI](https://polarean.com/684-2/)

## Pages

- [Home](https://polarean.com/)
- [Ethics & Compliance](https://polarean.com/about-polarean-imaging/ethics-compliance/)
- [The State of Lung Imaging](https://polarean.com/state-of-lung-imaging/)
- [Inquiries](https://polarean.com/xenon-mri-platform/platform-technology-support/)
- [The Xenon MRI Technology Platform](https://polarean.com/xenon-mri-platform/)
- [About Xenon MRI](https://polarean.com/about-xenon-mri/)
- [About Polarean](https://polarean.com/about-polarean-imaging/)
- [Clinical Research](https://polarean.com/xenon-mri-clinical-research/)
- [Privacy Policy](https://polarean.com/privacy-policy/)
- [About Xenon MRI - TEST](https://polarean.com/about-xenon-mri-test/)
- [News and Press Releases](https://polarean.com/about-polarean-imaging/news/)

## Categories

- [Uncategorized](https://polarean.com/category/uncategorized/)